Sorafenib priming may augment salvage chemotherapy in relapsed and refractory FLT3-ITD-positive acute myeloid leukemia

K. D. Cummins, S. M. Jane, S. Nikovic, Ali Bazargan, Robin J A Filshie, G Sutrave, Mark Hertzberg, A. Scott, S. Lane, C. K. Yannakou, Peter D. Ritchie, J. D'Rozario, J. Black, Ketan Bavishi, A. Wei

Research output: Contribution to journalLetterOtherpeer-review

3 Citations (Scopus)
Original languageEnglish
Article numbere237
JournalBlood Cancer Journal
Volume4
Issue number8
DOIs
Publication statusPublished - 2014

Cite this